Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JWN
1676
DELISTED
Nordstrom
JWN
| $903K | ﹤0.01% |
48,953
-76
| -0.2% | -$1.17K |
|
1677
NovoCure
NVCR
$1.73B
| $902K | ﹤0.01% |
60,398
-125
| -0.2% | -$1.67K |
|
1678
Vericel Corp
VCEL
$2.35B
| $894K | ﹤0.01% |
25,091
-36
| -0.1% | -$1.25K |
|
1679
Bio-Rad Laboratories Class A
BIO
$8.71B
| $890K | ﹤0.01% |
2,753
-16
| -0.6% | -$5.01K |
|
1680
IonQ
IONQ
$13.6B
| $889K | ﹤0.01% |
71,810
+57
| +0.1% | +$735 |
|
1681
Mercury Systems
MRCY
$5.83B
| $889K | ﹤0.01% |
24,320
-44
| -0.2% | -$1.59K |
|
1682
Kennametal
KMT
$2.59B
| $888K | ﹤0.01% |
34,454
-64
| -0.2% | -$1.54K |
|
1683
Construction Partners
ROAD
$5.84B
| $883K | ﹤0.01% |
20,285
-33
| -0.2% | -$1.35K |
|
1684
Delek US
DK
$4.16B
| $882K | ﹤0.01% |
34,186
-5,450
| -14% | -$144K |
|
1685
Outfront Media
OUT
$5.61B
| $882K | ﹤0.01% |
64,148
-97
| -0.2% | -$1.1K |
|
1686
Veeco
VECO
$3.05B
| $881K | ﹤0.01% |
28,404
+2,707
| +11% | +$75.4K |
|
1687
Diamondrock Hospitality Co
DRH
$2.71B
| $876K | ﹤0.01% |
93,189
-164
| -0.2% | -$1.38K |
|
1688
Global Net Lease
GNL
$1.84B
| $874K | ﹤0.01% |
87,793
-148
| -0.2% | -$1.29K |
|
1689
nCino
NCNO
$2.02B
| $873K | ﹤0.01% |
25,949
-30
| -0.1% | -$893 |
|
1690
St. Joe Company
JOE
$3.54B
| $873K | ﹤0.01% |
14,498
-44
| -0.3% | -$2.31K |
|
1691
Laureate Education
LAUR
$5.28B
| $873K | ﹤0.01% |
63,626
-106
| -0.2% | -$1.46K |
|
1692
Byline Bancorp
BY
$1.78B
| $870K | ﹤0.01% |
36,906
+18,685
| +103% | +$387K |
|
1693
Agilysys
AGYS
$2.97B
| $867K | ﹤0.01% |
10,234
-19
| -0.2% | -$1.54K |
|
1694
InvenTrust Properties
IVT
$2.76B
| $867K | ﹤0.01% |
34,220
-52
| -0.2% | -$1.3K |
|
1695
Huron Consulting
HURN
$2.41B
| $867K | ﹤0.01% |
8,424
-17
| -0.2% | -$1.75K |
|
|
RCM
1696
DELISTED
R1 RCM Inc. Common Stock
RCM
| $865K | ﹤0.01% |
81,766
-14,076
| -15% | -$160K |
|
1697
Arvinas
ARVN
$518M
| $861K | ﹤0.01% |
20,909
-30
| -0.1% | -$701 |
|
1698
CleanSpark
CLSK
$3.53B
| $861K | ﹤0.01% |
+78,075
| New | +$486K |
|
1699
WesBanco
WSBC
$3.97B
| $858K | ﹤0.01% |
27,329
-46
| -0.2% | -$1.24K |
|
1700
Talos Energy
TALO
$2.53B
| $856K | ﹤0.01% |
60,141
-133
| -0.2% | -$1.94K |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.